| REVIEW ARTICLE |
|
| Year : 2018 | Volume
: 2
| Issue : 2 | Page : 40-44 |
|
|
Research progress of hypertriglyceridemia and coronary heart disease
Yanyue Ji, Chunlin Bai
Department of Cardiology, Second Hospital of Shanxi Medical University, Taiyuan, China
Correspondence Address:
Dr. Chunlin Bai
Department of Cardiology, Second Hospital of Shanxi Medical University, Taiyuan
China
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/hm.hm_2_19
|
|
|
At present, the relationship between hypertriglyceridemia (HTG) and coronary heart disease (CHD) is still uncertain. In recent years, many researchers have tried to clarify the relationship between HTG, atherosclerosis, and CHD. This article will review the relationship between HTG and CHD from the aspects of epidemiology, pathogenesis, and cardiovascular benefits of HTG treatment to further understand the relationship between the two. Dyslipidemia is closely related to the occurrence and development of the atherosclerotic cardiovascular disease. Elevated low-density lipoprotein cholesterol (LDL-C) has been recognized as an independent risk factor for cardiovascular events. Statins can effectively reduce LDL-C and reduce the incidence of cardiovascular events. HTG is the most common dyslipidemia in China, and the correlation between HTG and CHD deserves attention. Therefore, as for the progress of HTG and CHD in recent years, we will make a review on the relationship between HTC and CHD, the mechanism of atherosclerosis and the cardiovascular benefits of treatment, so as to further clarify the role and significance of triglyceride in the process of atherosclerosis and provide new ideas for the prevention an d treatment of CHD. |
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
